why choose us

Clinical Trials Search

Showing 9,780 of 132,963 result(s)
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia

Status: Completed

Condition: Analgesia

Interventions: buprenorphine for 300mcg buccal administration

Date: 2023-08-01

Behavioral Health Interdisciplinary Program - Collaborative Chronic Care Model (BHIP-CCM) Enhancement Project 2.0

Status: Completed

Condition: Mental Health

Interventions: Implementation Facilitation involves and External Facilitator (from outside of the participating medical center) and an Internal Facilitator (from ins

Date: 2023-08-01

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed;Refractory MDS & AML

Status: NOT_YET_RECRUITING

Condition: AML;MDS

Interventions: Danvatirsen (AZD9150) is a selective, high-affinity, antisense oligonucleotide inhibitor of signal transducer and activator of transcription 3 (or STA

Date: 2023-08-01

Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome

Status: Completed

Condition: Cystic Fibrosis

Interventions:

A CultureSwab MaxV(+) (BD, Franklin Lakes, NJ) will be placed under endoscopic visualization to the middle meatus through a sterile sheath (red rub

Date: 2023-08-01

Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal

Status: NOT_YET_RECRUITING

Condition: Opiate Withdrawal Syndrome

Interventions:

lofexidine tablets 0.18mg tabs

pregabalin capsules 100mg and 25mg

Date: 2023-08-01

Lamivudine and Plasma Markers of Inflammation in Retinal Detachment

Status: Completed

Condition: Retinal Detachment

Interventions: Drug to be taken once daily for three days (two days prior to surgery and on the morning of surgery)

Date: 2023-08-01

Disparities Among Liver Transplant Patients

Status: Completed

Condition: End Stage Liver DIsease

Interventions:

Date: 2023-08-01

A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy Participants

Status: NOT_YET_RECRUITING

Condition: Healthy Participants

Interventions: Specified dose on specified days

Date: 2023-08-01

BioFLO for Respiratory Recovery in SCI

Status: Completed

Condition: Spinal Cord Injuries

Interventions: AIH (acute intermittent hypoxia) consists of short episodes of low oxygen (9% O2).

Date: 2023-08-01

Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects

Status: Completed

Condition: Healthy

Interventions: Oral administration by capsules (1 mg, 5 mg, or 25 mg).

Date: 2023-08-01